Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia

Overview of attention for article published in Cochrane database of systematic reviews, December 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 11 tweeters
facebook: 1 Facebook page

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 106 Mendeley

Summary Twitter Facebook Wikipedia Dimensions citations

So far, Dimensions has found 20 publications that cite this research output.

20

The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.

A Global Assessment of Eye Health and Quality of Life

Article in JAMA Ophthalmology (February 2021)

Ranibizumab for myopic choroidal neovascularization

Article in Expert Opinion on Biological Therapy (October 2020)

Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimens

Article in British Journal of Ophthalmology (November 2019)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.